Reports for CHEPLAPHARM ARZNEIMITTEL GMBH

Company Name

CHEPLAPHARM ARZNEIMITTEL GMBH

Totals

Shortage reports

48

Actual shortage: 7 (15%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (2%)
Resolved: 40 (83%)

Discontinuation Reports

4

To be discontinued: 0 (0%)
Discontinued: 4 (100%)
Reversed: 0 (0%)

Late reports

4 (8%)

Overdue reports

4 (57%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VISUDYNE 15MG POWDER FOR SOLUTION Resolved 2024-01-04 2024-03-01 214845
XENICAL 120MG CAPSULE Resolved 2021-05-13 2021-08-10 139254
INHIBACE PLUS 12.5MG 5MG TABLET Resolved 2022-05-09 2022-05-25 160204
INHIBACE PLUS 12.5MG 5MG TABLET Resolved 2022-08-17 2022-09-30 166884
RYTHMODAN 100MG CAPSULE Resolved 2021-11-18 2022-03-09 149615
RIVOTRIL 0.5MG TABLET Resolved 2017-11-07 2017-12-13 28573
RIVOTRIL 0.5MG TABLET Resolved 2018-01-03 2018-04-21 34871
RIVOTRIL 0.5MG TABLET Resolved 2022-10-12 2023-04-01 171577

Showing 41 to 48 of 48

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
XELODA 500MG TABLET Discontinued 2022-11-30 2022-12-01 176359
LOSEC 20MG TABLET (DELAYED-RELEASE) Discontinued 2021-11-19 2021-11-19 149669
XELODA 150MG TABLET Discontinued 2022-11-30 2022-12-01 176355
SUPREFACT 100MCG SOLUTION Discontinued 2021-12-13 2021-12-13 151039

Showing 1 to 4 of 4